Company profile
Bio-AMD company profile
Bio-AMD has three PoC technologies in development, each using a technology platform to be applied into specific market segments more. Their coagulation technology is in the feasibility stage of commercialization in conjunction with a global hematology major more, in line with our business model that avoids the costs and risks of “go-it-alone” development . The PoC market is growing fast. Forecasters suggest 10% growth per annum over the next few years will make the total market global worth over $22 billion.
Business identity
- Website
- http://www.bioamd.com/
- Phone number
- +44 (0) 1925 606 471
- Operating status
- Active
- Company type
- For Profit
- Founded
- 2006-01-01
Headquarters
- Headquarters
- Daresbury, England, United Kingdom
- Postal code
- WA4 4FS
- Country code
- GB
- Continent
- Europe